BEAM - CIK 0001745999
The table below shows Beam Therapeutics Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $288.29M | $267.96M | $282.13M | $527.91M | $230.20M | $292.76M |
| Short-term investments | $923.36M | $807.01M | $868.21M | $692.04M | $695.55M | $715.40M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.27B |
| $1.10B |
| $1.18B |
| $1.25B |
| $945.53M |
| $1.03B |
| Property, plant & equipment | $101.25M | $108.29M | $108.82M | $109.57M | $113.50M | $117.47M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.48B | $1.31B | $1.39B | $1.47B | $1.17B | $1.26B |
| Accounts payable | $12.29M | $9.54M | $10.56M | $7.70M | $3.81M | $4.43M |
| Total current liabilities | $74.56M | $182.56M | $174.13M | $141.55M | $166.24M | $177.33M |
| Long-term debt | $100.19M | - | - | - | - | - |
| Total liabilities | $316.36M | $345.08M | $344.34M | $343.78M | $380.05M | $407.17M |
| Retained earnings | -$1.74B | -$1.89B | -$1.78B | -$1.68B | -$1.48B | -$1.38B |
| Total equity | $1.16B | $966.00M | $1.05B | $1.12B | $791.32M | $854.09M |